Primary Site >> Liver Cancer
Gene >> SSTR2
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo. PMID: 10811995 Ref: Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. PMID: 11004697 |
Ref: In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial. PMID: 11965610 |
Ref: Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas. PMID: 15246216 Ref: Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells. PMID: 15456543 |
Ref: Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice. PMID: 15991301 Ref: [The study of inhibition effect of octreotide on the growth of hepatocellular carcinoma xenografts in situ in nude mice]. PMID: 16008961 |
Ref: [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]. PMID: 17626741 |
Ref: Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma. PMID: 19590186 Ref: [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice]. PMID: 19624890 Ref: [Induction of necrosis in the hepatocellular carcinoma HepG2 xenografts treated with SOM230]. PMID: 19874692 |
Ref: Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survival. PMID: 22870795 |
Ref: Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment. PMID: 24137418 |
Ref: Hepatic somatostatin receptor 2 expression during premalignant stages of hepatocellular carcinoma. PMID: 24163059 |
Ref: SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors. PMID: 25319765 |
Ref: Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis. PMID: 27391928 Ref: [Differences of Therapeutic Efficacy Between Different Kinds of Somatostatin Analogue for Primary Hepatocellular Carcinoma]. PMID: 28752973 Ref: Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets. PMID: 29282035 |